MRI-Guided radiation trial aims to control tough lung cancers

NCT ID NCT03916419

Summary

This study tested whether using MRI guidance could make radiation treatment more precise for people with inoperable, advanced non-small cell lung cancer. Twenty-six participants received a combination of targeted radiation, chemotherapy, and an immunotherapy drug called durvalumab. The main goals were to see if this approach was safe and effective at controlling the cancer in the chest area.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.